Skip to main content

Press Releases

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.

Kane Biotech to Showcase bluestem™ Pet Oral Care Products and New Skin Care Shampoo at the 14th Annual Global Pet Expo

WINNIPEG, Manitoba, March 20, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that for the third consecutive year it will be attending the 14th Annual Global Pet Expo being held on March 21-23, 2018 at the Orange County Convention Center in Orlando, Florida. Mark Ahrens-Townsend, Chief Executive Officer, will be attending the Expo to help showcase Kane Biotech’s bluestem™ brand of premium pet oral care products and to introduce the Corporation’s new bluestem™ skin care shampoo for dogs and cats.

Biostem Expo Booth
Kane Biotech’s Booth on bluestem™ at the Global Pet Expo


Kane Biotech will be at booth #5874 with a display promoting the benefits of their proprietary coactiv+™ technology – a unique formulation scientifically developed to break down biofilm where harmful bacteria multiply. “I personally invite all buyers attending Global Pet Expo to visit our booth and learn more about our innovative, clinically proven, safe and effective bluestem products,” says Ahrens-Townsend. “We are currently sold in 900 pet specialty stores in Canada and the U.S. and we look forward to building on those numbers at Global this year.” Bluestem oral care is available in a water additive, toothpaste, and oral spray.

Kane Biotech will also be introducing its new bluestem™ skin care shampoo, scheduled for commercialization this year. The shampoo is scientifically formulated to support the natural defenses of the skin to improve the skin condition and coat of dogs and cats (and horses too). The new formulation soothes and moisturizes skin irritations, itching, redness and dryness and helps cleanse minor wounds. “We encourage pet retailers to stop by the booth and ask for a free sample bottle. We’d love for you to try it on your pet and provide us with feedback,” says Ahrens-Townsend.

Biofilms are estimated to be involved in 80% of animal and human bacterial infections, including tooth decay, skin disorders, hospital acquired infections (HAIs), chronic wounds, and foodborne disease outbreaks. Kane Biotech has several formulations in development for both animal and human applications, based on its patented and patent-pending antibiofilm technologies.

Investors attending the conference who would like to meet with Kane Biotech management are encouraged to contact Kane Biotech Investor Relations at tpatel@edisongroup.com.

Global Pet Expo, presented by the American Pet Products Association (APPA) and Pet Industry Distributors Association (PIDA), is the pet industry's largest annual trade show featuring the newest, most innovative pet products on the market today. For the past 50 years, PIDA’s mission has been to enhance the well-being of wholesaler-distributors and to promote partnerships with their suppliers and customers.

At Global Pet Expo, more than 1,000 companies from around the world showcase the latest and greatest products available for all types of pets including dogs, cats, birds, fish, reptiles, small animals and horses. The Show features 16 football fields’ worth of pet products, more than 3,000 product-launches and 270 first-time exhibiting companies.

About American Pet Products Association (APPA)

The American Pet Products Association (APPA) is the leading trade association serving the interests of the pet products industry since 1958.  APPA membership includes more than 1,200 pet product manufacturers, their representatives, importers and livestock suppliers representing both large corporations and growing business enterprises.  APPA's mission is to promote, develop and advance pet ownership and the pet product industry and to provide the services necessary to help its members prosper. APPA is also proud to grow and support the industry through the following initiatives: Pets Add Life (PAL), the Human Animal Bond Research Institute (HABRI), The Pet Leadership Council (PLC), the Pet Industry Joint Advisory Council (PIJAC), Bird Enjoyment and Advantage Koalition (BEAK), and the Pet Care Trust.  Visit www.americanpetproducts.org for more information.

About Pet Industry Distributors Association (PIDA)

Pet Industry Distributors Association (PIDA) has represented the interests of pet product distributors since 1968. The mission of PIDA is to enhance the well-being of the wholesaler-distributor, to promote partnerships with their suppliers and customers and to work cooperatively with other organizations in fostering the human-companion animal bond. Visit www.pida.org for more information.

About Kane Biotech Inc.
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Corporation has a portfolio of biotechnologies, intellectual property (75 patents and patents pending, trade secrets and trademarks) and products developed by the Corporation’s own biofilm research expertise and acquired from leading research institutions. StrixNB™, DispersinB®, Aledex®, bluestem™, AloSera™, coactiv+™ and Kane® are trademarks of Kane Biotech Inc.   The Corporation is listed on the TSX Venture Exchange under the symbol "KNE" and on the OTCQB Venture Market under the symbol “KNBIF.”

For more information, please visit www.kanebiotech.com or contact:

Mark Ahrens-Townsend
President & CEO, Kane Biotech Inc.                                              
ir@kanebiotech.com
+1 (204) 477-7592

Tirth Patel
Edison Advisors
Investor Relations
tpatel@edisongroup.com
+1 (646) 653-7035

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/54d5982c-98a8-4d32-83a7-9a00deccaca5

Primary Logo

Source: Kane Biotech Inc.